FDA Outlines “Plausible Mechanism” Approval Pathway for Personalized Therapies, But …

21 U.S.C. § 355(d). FDA Direct: Catching Up on Agency Reforms, FDA.gov (Nov. 13, 2025), https://www.fda.gov/news …